Furthermore, Boehringer Ingelheim and Zealand Pharma A/S announced the initiation of phase 2 clinical trial for its dual-acting GLP-1/glucagon receptor agonist, BI 456906 in September 2019
Signing up is free, and over 35,000 partner pharmacies nationwide accept the coupons
( Epub 2019 Jul 11 PMID: 31296642 ) Ornelas C, Caiado J, Lopes A, Pereira Dos Santos MC, Pereira-Barbosa M (2018) Anaphylaxis to long-acting release exenatide
Iriondo C, Pedoia V, Majumdar S (2020) Lumbar intervertebral disc characterization through quantitative MRI analysis: an automatic voxel-based relaxometry approach
A novel model of diabetic complications: adipocyte mitochondrial dysfunction triggers massive beta-cell hyperplasia
A pooled analysis of clinical trials found that ginger supplements could reduce SBP by 6.36 mmHg and DBP by 2.12 mmHg (566)